U.S. Large Molecule Drug Substance CDMO Market Size, Share &...

agregó una foto Health

2026-07-12 20:39:14 - Translate

U.S. Large Molecule Drug Substance CDMO Market Size, Share & Forecast 2026–2034

The increasing complexity of biologic medicines is transforming pharmaceutical manufacturing across the United States. As biotechnology companies accelerate the development of monoclonal antibodies, recombinant proteins, vaccines, and advanced cell-based therapies, demand for specialized contract manufacturing services continues to rise. The latest Polaris Market Research report indicates that...

0 Commentarios 0 Acciones 2K Views 0 Vista previa